Purchase Order 36C24825P0636

Award Date 1/29/25
Potential Completion Date 3/28/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of TFH 9000 OPTUNE PLUS TRANSDUCERS for the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $84,000.00 firm fixed-price purchase order, awarded on June 29, 2020, has an ultimate completion date of December 29, 2020. The contract does not utilize any set-aside designations. Novocure is the prime contractor and is delivering its...
This federal contract award is for the monthly rental of Optune and transducer devices from Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $16,582.91 firm fixed-price contract was awarded on May 28, 2025 by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for a period ending on June 30, 2025. Novocure specializes in innovative cancer therapy technologies, with its primary product being the Optune system, which utilizes Tumor...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the delivery of the Optune Plus Transducers system to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $33,165.82 and is structured as a firm fixed-price delivery order, running through June 30, 2025. Novocure, acting as the prime contractor, will provide the Optune medical devices, transducer arrays, rental equipment,...
This federal contract award to Novocure Inc. is for the procurement of the company's Optune Plus Transducers product line, a cancer therapy device that delivers Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price contract was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and is not set aside. Novocure, a foreign-owned for-profit manufacturer, holds a 5-year Federal Supply Schedule (FSS) contract...
This federal contract award is for the delivery of Optune Plus Transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm fixed-price contract was awarded to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, on December 18, 2024, with a completion date of December 17, 2025. Novocure is the prime contractor and will deliver its proprietary Optune medical device technology, including therapy devices, transducer...
This federal contract award is for the provision of Novocure Inc.'s Optune Plus Transducer Therapy System to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this $49,748.73 firm-fixed-price delivery order contract. The contract, which does not utilize any set-aside designations, was awarded on March 27, 2024, with a period of performance through June 26, 2024....
This federal contract award is for the delivery of Optune Plus transducer devices by Novocure Inc., a foreign-owned, for-profit medical device manufacturer, to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm fixed-price contract (Award ID: 36F79723D0016|36C25525K0362) has an ultimate completion date of June 30, 2025 and was awarded on April 15, 2025. Novocure provides the Optune system, which utilizes Tumor Treating Fields (TTFields)...
This federal contract award is for the renewal of Optune Plus transducers by Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $45,600.00 firm fixed-price delivery order was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under a 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with a ceiling value of $28.85 million. The contract does not utilize any set-aside designations. Novocure, acting as the prime...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, a component of the company's Tumor Treating Fields (TTFields) cancer therapy technology, over a 3-month period. This award is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award to Novocure Inc., a foreign-owned manufacturer of medical devices, is for the provision of Optune Plus transducers, device rentals, and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is a Firm Fixed Price delivery order awarded under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. This multiple-award...

This federal contract award is for the procurement of Optune Plus transducers from Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $16,582.91 firm-fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc. as the prime contractor. The contract has an ultimate completion date of March 28, 2025 and does not utilize any set-aside designations.

Novocure Inc. provides its proprietary Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the VA VHA through federal contract awards, including a 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with a $28.85 million ceiling value. This FSS contract, awarded in November 2022, serves as a streamlined procurement vehicle for the VA to efficiently obtain Novocure's innovative cancer treatment technologies for distribution to VA medical centers nationwide, supporting the VA's mission of expanding veterans' access to cutting-edge therapies.

Generated 1/30/25, 9:08 AM